ArticleBMC infectious diseases2025
The performance of low HIV viral load values for the diagnosis of acute HIV infection in the Beijing PRIMO cohort.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEarly diagnosis is critical for the prompt initiation of antiretroviral therapy (ART) and the prevention of secondary HIV transmission. China's diagnostic guidelines recently lowered the viral load (VL) threshold from 5,000 to 1,000 copies/mL. However, under the current Western blot (WB)-based confirmation system, the diagnostic significance of VL < 1,000 copies/mL during acute HIV infection (AHI) remains unclear. This study aimed to assess the impact of low VL on AHI diagnosis.
methodsThis study utilized data from the Beijing PRIMO prospective cohort conducted between 2006 and 2013, enrolling 347 individuals at high risk for HIV infection. HIV RNA levels were tested every two months to screen for acute HIV-1 infection. By analyzing the association between VL and confirmatory WB antibody results among the 347 participants in the PRIMO cohort, we aimed to assess the diagnostic utility of low VL levels in identifying AHI. In addition, the characteristics of the CD4/CD8 T-cell ratio were evaluated.
resultsAmong the 347 participants in the Beijing PRIMO cohort, 4 cases (1.15%) had VL < 1,000 copies/mL prior to obtaining a confirmed positive antibody result, with 3 of these cases showing a transition from indeterminate to positive WB results. The longest interval observed between a VL < 1,000 copies/mL and a subsequent positive WB result was 42 days. Additionally, 12 participants had at least one VL measurement between 1,000 and 5,000 copies/mL before confirmation of WB positivity. Among 112 participants with available CD4/CD8 T-cell ratio data from the time of, or prior to, confirmed WB positivity, 109 (97.3%) exhibited a CD4/CD8 T-cell ratio of < 1.0.
conclusionLowering the VL threshold to 1,000 copies/mL can reduce missed diagnoses; however, VL < 1,000 copies/mL during AHI may still delay diagnosis under the WB-based system. Nucleic acid testing (NAT) should be prioritized for individuals with high-risk profiles and negative or indeterminate antibodies to shorten the diagnostic window and enable earlier ART initiation. These findings provide real-world evidence supporting recent guideline changes and underscore the diagnostic challenges posed by low VL. The study also supports broader NAT adoption to enhance early detection and reduce AHI underdiagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.